StockData
Cellectis S.A. logo

Cellectis S.A. (CLLS) stock

CLLSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 20, 2026Score 3/30
$1.06+0.02 (+1.92%)

Close on Nov 17, 2026Market cap $106.36MP/E –Yield –

Cellectis total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

No total debt figures for Cellectis

Cellectis has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Cellectis figures

See a number that looks wrong?